A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
about
An outline of necrosome triggersInterleukin-1 Family Cytokines in Liver DiseasesDeath in the fast lane: what's next for necroptosis?Role of necroptosis in the pathogenesis of solid organ injuryThe necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance.Molecular Pathogenesis of NASHQuestions and controversies: the role of necroptosis in liver diseaseTargeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic SteatohepatitismiR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in miceMechanisms of acetaminophen hepatotoxicity and their translation to the human pathophysiology.Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic Steatohepatitis.The role of the c-Jun N-terminal kinases 1/2 and receptor-interacting protein kinase 3 in furosemide-induced liver injuryDifferential hepatotoxicity of dietary and DNL-derived palmitate in the methionine-choline-deficient model of steatohepatitis.Cell death and cell death responses in liver disease: mechanisms and clinical relevanceRegulation of NKT cell-mediated immune responses to tumours and liver inflammation by mitochondrial PGAM5-Drp1 signalling.High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosisNecrostatin-1 reduces intestinal inflammation and colitis-associated tumorigenesis in miceDifferential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death.Activation of necroptosis in human and experimental cholestasis.Distinct Kinase-Independent Role of RIPK3 in CD11c+ Mononuclear Phagocytes in Cytokine-Induced Tissue RepairImmunoregulation by lipids during the development of non-alcoholic steatohepatitis.Hepatocytes in liver injury: Victim, bystander, or accomplice in progressive fibrosis?Host homeostatic responses to alcohol-induced cellular stress in animal models of alcoholic liver disease.Pathophysiological mechanisms and therapeutic potentials of macrophages in non-alcoholic steatohepatitis.TNFα in liver fibrosis.The in vivo evidence for regulated necrosis.The Inflammatory Signal Adaptor RIPK3: Functions Beyond Necroptosis.Sibiriline, a new small chemical inhibitor of receptor-interacting protein kinase 1, prevents immune-dependent hepatitis.Necroptosis: Mechanisms and Relevance to Disease.Necroptosis in Nonalcoholic Steatohepatitis.Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis.Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-κB.Receptor interacting protein 3 protects mice from high-fat diet-induced liver injuryAcetaminophen knocks on death's door and receptor interacting protein 1 kinase answers.Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death.Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice.The JNK Signaling Pathway in Renal Fibrosis.Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis.miRNA-21 ablation protects against liver injury and necroptosis in cholestasis.Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression.
P2860
Q26751108-75720C40-D6A6-44A6-9F89-4DC118F53939Q26778553-75447AFE-7709-4E57-AE6F-2AFD596BD159Q26782124-1EB8889B-0E31-4B67-9907-08D383F51B52Q27023218-7CBBBA7C-D8A3-4702-8D6C-C3C6286D82CCQ27313354-04F5EA37-4114-45AD-9649-D2AC00623A21Q28071265-7E770642-C3A8-46F1-BABF-2BBF05EE2BD9Q28072789-16414414-EDF1-4BA7-900A-BD5F98314AC3Q28077079-B234783B-4FEC-467E-AAF7-7FAD6462C8F5Q33815927-058010E5-C765-4E20-8B8F-78E4309A51A4Q33848167-DEBB223B-DE39-402E-911A-2446803C0626Q35122049-0E50AC7D-A254-4F86-825C-B239C080B5FAQ35642533-16EAD249-EBA7-4D70-BDEC-47EB1D1DE002Q35672132-6E58C6FB-3AD8-427B-B7AB-4044424F5B2DQ35938040-E5E29581-2568-48AC-8DA7-9D40EC43A0E8Q36077924-290617D2-705E-4512-8921-99266859071FQ36190325-5AB33261-67D7-43A0-BAA2-92DBC6C0F9ECQ36309417-7A83C90B-9023-4A5B-9F9D-9999209489BCQ36347249-B661DF5C-B1B6-4211-9145-9DDB9BBE6F96Q37330901-45386C8F-DF97-4F6F-BC79-725364BF6BC2Q37690521-0D5DBF23-4E4D-45EA-8F44-45AA9C5A3B72Q38365029-73995EBC-D08A-49DE-A3EF-ED856C597902Q38560320-BCF76E67-069A-42EE-B926-31CE7354D1EAQ38570690-4977C67B-0A30-4A02-8ABD-0CE4DED95806Q38648556-A8704966-AA42-4E53-B277-AF116498FC75Q38685726-A568872F-686F-4A4C-A3DA-B685332103D4Q38809791-ABDA0298-6DF8-4E20-800A-42F4424A21C9Q39077160-EEC6A587-BAA0-4FEE-8055-72DB6CDFA4ABQ40132104-789E778C-D552-4B55-B12C-8CA99C6A01A5Q40411907-806881E2-1BCC-42C1-A7E8-90DE3FA7C4C0Q41781980-6360C8BC-5E79-4CBE-B73B-D3E59D02581BQ42367659-C9B474B9-90BD-445E-8A86-59C60EBC6C5BQ42371937-50A42143-CBC1-4B71-8FA2-C24FF87B488AQ42713681-726DB4E0-A7FD-4CBF-989D-E6EEA9F5E5C8Q43126056-79990569-3348-4A56-81CC-0886AD5AEF98Q43951595-8D308FC8-592A-46C7-B119-31E88AE8B725Q45711851-45FCA540-13C3-497C-BD43-8E7AF5B2948FQ45967786-1712B40F-FCE9-4317-9AF8-480750590FCAQ46109785-617290C5-49D9-4775-9FE6-D5364F49E128Q47304510-F4FB82E7-DBDD-4E5B-BD8B-F3761E7F4D82Q47589822-868A7910-A20B-41B4-AA04-555871546183
P2860
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
@ast
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
@en
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
@nl
type
label
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
@ast
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
@en
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
@nl
prefLabel
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
@ast
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
@en
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
@nl
P2093
P2860
P356
P1476
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
@en
P2093
Ali Canbay
Anne Theres Schneider
Christian Trautwein
Christiane Koppe
Christoph Roderburg
David Vargas Cardenas
Florian Reisinger
Frank Tacke
Helen Louise Reeves
Jérémie Gautheron
P2860
P304
P356
10.15252/EMMM.201403856
P577
2014-06-24T00:00:00Z